Europe South Asia Asia Pacific Americas Middle East Africa BBC Homepage World Service Education



Front Page

World

UK

UK Politics

Business

Sci/Tech

Health

Education

Sport

Entertainment

Talking Point

In Depth

On Air

Archive
Feedback
Low Graphics
Help

Wednesday, May 5, 1999 Published at 00:19 GMT 01:19 UK


Health

Pfizer goes to court over Viagra

Viagra is at the centre of the NHS rationing debate

The makers of Viagra are taking the UK Government to court next week over its handling of the anti-impotence drug.

Viagra
Pfizer alleges that the government acted unlawfully last year when it issued guidance to doctors, advising them to refrain from prescribing the drug until further notice.

The Department of Health, which is expected to deny the allegations, feared that excessive demand for Viagra could cost the health service more than £1bn a year.

The drug was licensed for use in the European Union in September.

In January, the government issued further guidance to doctors, restricting the prescription of Viagra to men with specific medical conditions.

Consultation on this advice ended on 25 March and the government is still considering the results.

The British Medical Association has advised doctors that they have a contractual obligation to prescribe the drug to anyone with a clinical need.

It says the government's restrictions, which it calls "irrational and misguided", mean only 15% of patients with a clinical need will get the drug.

However, NHS managers, worried about their budgets, support it.

Judicial review

Pfizer's court action, which is due to begin next Monday or Tuesday, relates solely to last year's guidance.


Joshua Rozenberg: "Pfizer says it is taking legal action as a matter of principle"
It is seeking a judicial review of the guidance, saying the government acted illegally by not giving a good reason for its decision.

"They did not react quickly after issuing the advice and we have to protect our business interests," said a spokesman for Pfizer. It is a point of principle."

Pfizer says the government has received 850 replies to its consultation on Viagra.

About 250 have been copied to the company.

"They are more or less unanimous that the proposals are unfair and discriminatory," said the spokesman.

However, he added that, if the government decided to go ahead with its plans to restrict Viagra and legislated for them, it would not be able to take legal action - as it has over last year's guidance.

Difficult position

But he said the proposals would put doctors in a difficult position.

"They will not want to go against their employer, but it is hard to sit opposite a patient with an erectile dysfunction who has had the courage to speak to someone about it."

He added that the media hype had made people realise that impotence was a medical condition, that it could be treated and that they were not alone.

"After being turned away by the majority of doctors following the government's advice many men will never go back.

"That means doctors will miss the opportunity to diagnose the underlying cause of their impotence and it could be left until it is much more serious," he stated.



Advanced options | Search tips




Back to top | BBC News Home | BBC Homepage | ©


Health Contents

Background Briefings
Medical notes

Relevant Stories

26 Mar 99†|†Viagra
NHS bosses: Restrict Viagra

25 Mar 99†|†Viagra
'Give impotent men Viagra'

24 Mar 99†|†Viagra
Pressure mounts for Viagra U-turn

25 Jan 99†|†Viagra
Viagra patients could sue, says doctor

28 Jan 99†|†Viagra
Viagra impotence warning

21 Jan 99†|†Viagra
Doctors: why we oppose Viagra rationing

04 Jan 99†|†Viagra
Viagra rival set for licence

18 Dec 98†|†Viagra
GPs issue Viagra warning

15 Dec 98†|†Viagra
Channel Island firms bypass Viagra ban





Internet Links


Pfizer

Department of Health

British Medical Association


The BBC is not responsible for the content of external internet sites.




In this section

Disability in depth

Spotlight: Bristol inquiry

Antibiotics: A fading wonder

Mental health: An overview

Alternative medicine: A growth industry

The meningitis files

Long-term care: A special report

Aids up close

From cradle to grave

NHS reforms: A guide

NHS Performance 1999

From Special Report
NHS in crisis: Special report

British Medical Association conference '99

Royal College of Nursing conference '99